The metastatic spread of cancers correlates with the expression of stem cell biomarkers CD133, CD44, ALDH1, and OCT4 [2, 47–50], which was significantly increased in CRC cells overexpressing B7-H3 (Fig. 2). Here, CD276 is linked to cancer.